SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4026i sold my latest isis position for a decent gain and replaced it with some in thbob zagorin-3/23/2007
4025Isis Pharmaceuticals Announces Its Participation at the Upcoming ACC 56th Annualkenhott-3/22/2007
4024>>Mol Pharmacol. 2005 Jan;67(1):69-77. Epub 2004 Oct 8. Ertiprotafib imprtuck-3/21/2007
4023<reply> Thanks. n=8 per cohort not per arm. That would have been a smalkenhott-3/21/2007
4022March 25th/26th ACC with update of 5wk multi-dose phase 2 ISIS301012 + statin ankenhott-3/21/2007
4021Future Of Cholesterol Drugs Put To Test At Heart Meeting DOW JONES NEWSWIRES Mabob zagorin-3/21/2007
4020accoridng to a DJ story, isis will present escalated dose studies on 301012 at Abob zagorin-3/20/2007
4019Coverage Resumed Sort alphabetically | Sort by brokers Company Ticker Brokerabob zagorin-3/20/2007
401810k: xml.10kwizard.combob zagorin-3/16/2007
4017MTSL (John McCamant) interview makes isis one of three likely pharma buyouts.. mbob zagorin-3/9/2007
4016Isis Pharmaceuticals Reports Financial Results and Highlights for Fiscal Year 20bob zagorin-3/8/2007
4015IPO window shuts on OncoGenex: Message 23351551 Not a huge surprise, and ISIS tuck-3/8/2007
40146-Mar-2007 Entry into a Material Definitive Agreement, Financial Statements andbob zagorin-3/6/2007
4013OncoGenex is trying to get out the IPO window. This is important because part otuck-3/5/2007
4012Alnylam and Isis Announce Allowance of First U.S. Patent Covering Human microRNAbob zagorin-3/2/2007
4011Eye on Alnylam: Silencing the Gene Tuesday February 6, 6:40 am ET (seeking alphabob zagorin-2/6/2007
4010thanks tuck. i've also been trading isis for over 10 years and amazingly whebob zagorin-2/5/2007
4009[ISIS 113715: PTP-1B inhibitors versus breast cancer] >>Nat Genet. 2007 Jtuck-2/5/2007
4008xml.10kwizard.combob zagorin-1/22/2007
4007Isis Pharmaceuticals Enters Into an Agreement to Sell $125.0 Million Convertiblebob zagorin-1/18/2007
4006SeekingAlpha Expecting a Big Move in Isis Pharma Wednesday January 10, 9:45 am Ebob zagorin-1/11/2007
4005Isis Development Partner iCo Therapeutics Files IND for Antisense Drug to Treat bob zagorin-12/21/2006
4004European Patent Office Upholds Key Isis Patent Protecting Antisense Structures Wbob zagorin-12/20/2006
4003Lilly Highlights Two Collaboration Drugs in Its Pipeline Update Monday December nigel bates-12/11/2006
4002Isis Receives $1 Million Milestone Payment From Merck on Initiation of Clinical bob zagorin-12/5/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News